Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The COVID virus infected coronary arteries and increased inflammation in atherosclerotic plaques.
Infants and young children who had COVID produced protective antibodies for much longer than adults.
New study shows hospitalizations would fall by more than 50% and emergency department visits by over 30%.
The live-attenuated vaccine aims to produce an immune response to the entire virus rather than the frequently mutating spike protein.
Study findings shed light on possible causes of long COVID and could lead to more sensitive testing and personalized treatments.
The protein-based vaccine works in a different way than the mRNA vaccines from Moderna and Pfizer-BioNTech.
The technology, developed by Katalin Karikó and Drew Weissman, also holds promise for HIV vaccines and cancer treatment.
NIH-funded research sheds light on link between COVID-19 and increased risk of cardiovascular disease and stroke.
Report findings suggest many cancers were not being diagnosed in a timely manner during the early part of the pandemic.
Study findings identify a potential marker that could help identify people at high risk of developing long COVID.
Mitochondrial dysfunction has been found in some people with long COVID and other conditions that include fatigue.
Research on the links between tenofovir and other antiretrovirals, SARS-CoV-2 infection and COVID severity has produced mixed results.
Learning how the virus survives in nature and transmits among animals could help predict future SARS-CoV-2 evolution.
Stopping the virus from hijacking mitochondrial energy production may be a novel way to prevent serious complications.
NIH-funded research links alterations to inflammatory protein, underscores vaccine importance.
COVID mortality declined overall during the omicron wave but less so for people with HIV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.